141 related articles for article (PubMed ID: 36118892)
41. A CT-Based Radiomics Nomogram to Predict Complete Ablation of Pulmonary Malignancy: A Multicenter Study.
Zhang G; Yang H; Zhu X; Luo J; Zheng J; Xu Y; Zheng Y; Wei Y; Mei Z; Shao G
Front Oncol; 2022; 12():841678. PubMed ID: 35223526
[TBL] [Abstract][Full Text] [Related]
42. Exploring the Value of Radiomics Features Based on B-Mode and Contrast-Enhanced Ultrasound in Discriminating the Nature of Thyroid Nodules.
Guo SY; Zhou P; Zhang Y; Jiang LQ; Zhao YF
Front Oncol; 2021; 11():738909. PubMed ID: 34722288
[TBL] [Abstract][Full Text] [Related]
43. MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer.
Qiu Y; Zhang X; Wu Z; Wu S; Yang Z; Wang D; Le H; Mao J; Dai G; Tian X; Zhou R; Huang J; Hu L; Shen J
Front Oncol; 2022; 12():811347. PubMed ID: 35296027
[TBL] [Abstract][Full Text] [Related]
44. Epithelial salivary gland tumors: Utility of radiomics analysis based on diffusion-weighted imaging for differentiation of benign from malignant tumors.
Shao S; Mao N; Liu W; Cui J; Xue X; Cheng J; Zheng N; Wang B
J Xray Sci Technol; 2020; 28(4):799-808. PubMed ID: 32538891
[TBL] [Abstract][Full Text] [Related]
45. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
Zheng Y; Zhou D; Liu H; Wen M
Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
[TBL] [Abstract][Full Text] [Related]
46. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer.
Liu S; He J; Liu S; Ji C; Guan W; Chen L; Guan Y; Yang X; Zhou Z
Eur Radiol; 2020 Jan; 30(1):239-246. PubMed ID: 31385045
[TBL] [Abstract][Full Text] [Related]
47. A Radiomics Approach for the Classification of Fibroepithelial Lesions on Breast Ultrasonography.
Sim Y; Lee SE; Kim EK; Kim S
Ultrasound Med Biol; 2020 May; 46(5):1133-1141. PubMed ID: 32102739
[TBL] [Abstract][Full Text] [Related]
48. Preoperative prediction of histologic grade in invasive breast cancer by using contrast-enhanced spectral mammography-based radiomics.
Mao N; Jiao Z; Duan S; Xu C; Xie H
J Xray Sci Technol; 2021; 29(5):763-772. PubMed ID: 34151880
[TBL] [Abstract][Full Text] [Related]
49. Single-Photon Emission Computed Tomography/Computed Tomography Image-Based Radiomics for Discriminating Vertebral Bone Metastases From Benign Bone Lesions in Patients With Tumors.
Jin Z; Zhang F; Wang Y; Tian A; Zhang J; Chen M; Yu J
Front Med (Lausanne); 2021; 8():792581. PubMed ID: 35059418
[No Abstract] [Full Text] [Related]
50. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.
Sellami S; Bourbonne V; Hatt M; Tixier F; Bouzid D; Lucia F; Pradier O; Goasduff G; Visvikis D; Schick U
Acta Oncol; 2022 Jan; 61(1):73-80. PubMed ID: 34632924
[TBL] [Abstract][Full Text] [Related]
51. Classification of MR-Detected Additional Lesions in Patients With Breast Cancer Using a Combination of Radiomics Analysis and Machine Learning.
Lee HJ; Nguyen AT; Ki SY; Lee JE; Do LN; Park MH; Lee JS; Kim HJ; Park I; Lim HS
Front Oncol; 2021; 11():744460. PubMed ID: 34926256
[TBL] [Abstract][Full Text] [Related]
52. A radiomics method to classify microcalcification clusters in digital breast tomosynthesis.
Peng Y; Wu S; Yuan G; Wu Z; Du Q; Sun H; Yang X; Chen Q; Zheng J
Med Phys; 2020 Aug; 47(8):3435-3446. PubMed ID: 32358973
[TBL] [Abstract][Full Text] [Related]
53. Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features.
Wen Q; Yang Z; Dai H; Feng A; Li Q
Front Oncol; 2021; 11():620246. PubMed ID: 34422625
[TBL] [Abstract][Full Text] [Related]
54. Radiomics With Attribute Bagging for Breast Tumor Classification Using Multimodal Ultrasound Images.
Li Y; Liu Y; Zhang M; Zhang G; Wang Z; Luo J
J Ultrasound Med; 2020 Feb; 39(2):361-371. PubMed ID: 31432552
[TBL] [Abstract][Full Text] [Related]
55. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
56. Preoperative diagnosis and prediction of hepatocellular carcinoma: Radiomics analysis based on multi-modal ultrasound images.
Yao Z; Dong Y; Wu G; Zhang Q; Yang D; Yu JH; Wang WP
BMC Cancer; 2018 Nov; 18(1):1089. PubMed ID: 30419849
[TBL] [Abstract][Full Text] [Related]
57. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
[TBL] [Abstract][Full Text] [Related]
58. Additive Benefit of Radiomics Over Size Alone in the Distinction Between Benign Lesions and Luminal A Cancers on a Large Clinical Breast MRI Dataset.
Whitney HM; Taylor NS; Drukker K; Edwards AV; Papaioannou J; Schacht D; Giger ML
Acad Radiol; 2019 Feb; 26(2):202-209. PubMed ID: 29754995
[TBL] [Abstract][Full Text] [Related]
59. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Benign and Malignant Pancreatic Lesions with DECT Quantitative Metrics and Radiomics.
Ebrahimian S; Singh R; Netaji A; Madhusudhan KS; Homayounieh F; Primak A; Lades F; Saini S; Kalra MK; Sharma S
Acad Radiol; 2022 May; 29(5):705-713. PubMed ID: 34412944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
